Stay updated on Pembrolizumab Maintenance in sNSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Maintenance in sNSCLC Clinical Trial page
- Check7 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6. This indicates a minor backend update to the study page version rather than a substantive change to the study details.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous v3.6.4. This update represents a small internal version change and does not alter study information or user-facing content.SummaryDifference0.1%

- Check43 days agoChange DetectedThe website revision was updated from v3.6.3 to v3.6.4, representing a newer platform release. There is no change to study data or page content reflected.SummaryDifference0.1%

- Check64 days agoChange DetectedThe revision indicator was updated from v3.6.2 to v3.6.3. This reflects an underlying site update but does not alter the study details or the information presented to users.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2. No user-facing content changes are indicated.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page now states recruitment has ended and introduces new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with the Intervention/Treatment heading and a revised revision tag (Revision: v3.6.0).SummaryDifference0.6%

Stay in the know with updates to Pembrolizumab Maintenance in sNSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.